Blake, Cassels & Graydon LLP

Corporate ＆ Commercial; Technology; Intellectual Property; Privacy; Communications

Tricia leads the Blakes Montréal Cannabis Group and is a key member of the Firm’s national Cannabis Group. She has a broad corporate and commercial practice, including advising licensed producers, processors, applicants, research teams, product developers, online publishers and equipment manufacturers, on a variety of regulatory, corporate and commercial matters in the medical, wellness and recreational cannabis industries. She focuses on mergers and acquisitions, divestitures, corporate reorganizations, joint ventures, processing, licensing and import/export arrangements, manufacturing, supply, marketing, distribution, quality assurance, research & development, shareholder and partnership agreements. She also provides legal risk assessments to financial and strategic investors in the cannabis industry.

Tricia acts for a variety of innovative companies and investors, notably in the life sciences, healthcare and technology sectors, who rely upon her legal expertise and experience to assist them with their cutting-edge projects. She advises domestic and international clients on their private M&A and complex commercial transactions, joint ventures, licensing agreements and biopharma partnerships and guides healthcare professionals, medical clinics and medical device manufacturers in their operations, including telemedicine and digital healthcare.